Shikonin-Loaded Nanoparticles Ameliorate DEHP-Exacerbated Psoriasis Skin Injury via Targeted Inhibition of the p38 MAPK Signaling Pathway
International Journal of Molecular Sciences · 08.08.2026 · 27 (16) · 7109
DOI: 10.3390/ijms27167109 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.08.2026. Verfasst von Qinghua Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Centre, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Naphthoquinones, p38 Mitogen-Activated Protein Kinases, Nanoparticles, Psoriasis. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Songgang People's Hospital, Bao'an District, Shenzhen, 2026 “Building Dreams, Setting Sail” Open Cooperation Fund for Scientific Research, Songgang People’s Hospital, Bao’an District, Shenzhen.
Abstract (Originalsprache)
Di-(2-ethylhexyl) phthalate (DEHP), a ubiquitous environmental plasticizer, has been increasingly linked to the exacerbation of inflammatory skin conditions, especially psoriasis. However, the mechanisms and effective therapeutic strategies targeting DEHP-aggravated psoriasis remain elusive. We integrated network toxicology, network pharmacology, and molecular docking to explore the targets of DEHP-exacerbated psoriasis and the protective effects of shikonin (SH). These findings were validated in a DEHP/IMQ-induced mouse model using a novel shikonin nanoparticle (SH-NP) that overcomes SH’s inherent hydrophobicity. Computational analyses revealed that SH counteracts DEHP skin toxicity through a multi-target network, identifying the p38 mitogen-activated protein kinase (p38 MAPK), TNF, IL-1β, proliferating cell nuclear antigen (PCNA), and matrix metalloproteinases 2 and 9 (MMP2/9) as core therapeutic nodes. Molecular docking verified this network, revealing robust binding between SH and key targets with binding energies ranging from −6.0 to −7.8 kcal/mol, consistently outperforming DEHP. In vivo experiments demonstrated that topical application of SH-NP significantly ameliorated macroscopic skin injury and reduced PASI scores. Mechanistically, SH-NP effectively reversed the DEHP-exacerbated inflammatory microenvironment by decreasing macrophage and mast cell infiltration in the dermis, reducing pro-inflammatory cytokine levels, and inhibiting the phosphorylation of p38 MAPK. Furthermore, SH-NP treatment successfully suppressed keratinocyte hyperproliferation, as evidenced by downregulated PCNA expression and reduced epidermal thickness. SH-NPs also markedly downregulated the elevated levels of MMP2/9 in mice, thereby mitigating collagen degradation and maintaining dermal matrix integrity. This study shows that SH-NPs alleviate DEHP-aggravated psoriasis by suppressing local inflammation, keratinocyte hyperproliferation, and collagen degradation, offering a targeted nanostrategy for environmentally exacerbated skin diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Centre, Guangzhou 510006, China.
- School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou Higher Education Mega Centre, Guangzhou 510006, China.
- School of Life Science and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Centre, Guangzhou 510006, China.
ORCID-Profile: Qinghua Tang, Lin Zhou, Ming Li
Förderung
- Songgang People's Hospital, Bao'an District, Shenzhen
- 2026 “Building Dreams, Setting Sail” Open Cooperation Fund for Scientific Research
- Songgang People’s Hospital, Bao’an District, Shenzhen
Zitieren
APA
Tang, Q., Li, Y., Li, Y., Wang, X., Bie, Y., Yu, X., Zhou, L., & Li, M. (2026). Shikonin-Loaded Nanoparticles Ameliorate DEHP-Exacerbated Psoriasis Skin Injury via Targeted Inhibition of the p38 MAPK Signaling Pathway. International Journal of Molecular Sciences, 27(16), 7109. https://doi.org/10.3390/ijms27167109
Vancouver
Tang Q, Li Y, Li Y, Wang X, Bie Y, Yu X, et al. Shikonin-Loaded Nanoparticles Ameliorate DEHP-Exacerbated Psoriasis Skin Injury via Targeted Inhibition of the p38 MAPK Signaling Pathway. International Journal of Molecular Sciences. 2026;27(16):7109. doi:10.3390/ijms27167109
BibTeX
@article{Tang2026,
author = {Tang, Qinghua and Li, Yixiong and Li, Yan and Wang, Xinyuan and Bie, Yanan and Yu, Xuesong and Zhou, Lin and Li, Ming},
title = {Shikonin-Loaded Nanoparticles Ameliorate DEHP-Exacerbated Psoriasis Skin Injury via Targeted Inhibition of the p38 MAPK Signaling Pathway},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {16},
pages = {7109},
doi = {10.3390/ijms27167109}
}
EUVIMED